$Purple Biotech (PPBT.US)$ Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups 1 hour ago, 4:00 AM PDT Via GlobeNewswire PPBT Share • Statistically significant efficacy in biomarker subgroup analyses was observed: ◦ 78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM...
$Purple Biotech (PPBT.US)$Purple Biotech's CM24 Shows Up To 90% Reduction In Death Risk In Pancreatic Cancer Patients, Biomarker Insights To Drive Next Phase 2b Study Benzinga· 5 mins ago Statistically significant efficacy in biomarker subgroup analyses was observed:78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM1 subgroup61% reduction is risk of death and 72% reduction in risk of progression or death ...
$Purple Biotech (PPBT.US)$ Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers Monday, 28th April at 8:28 am • Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer • NT219's mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapies REHOVOT, Israel, April 28, ...
$Purple Biotech (PPBT.US)$Purple Biotech To Present CM24 And NT219 Data For Pancreatic, Colorectal, And Head And Neck Cancers At 2025 AACR Meeting April 25-30th
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Purple Biotech Stock Forum
Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups
1 hour ago, 4:00 AM PDT
Via GlobeNewswire
PPBT
Share
• Statistically significant efficacy in biomarker subgroup analyses was observed:
◦ 78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM...
Benzinga· 5 mins ago
Statistically significant efficacy in biomarker subgroup analyses was observed:78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM1 subgroup61% reduction is risk of death and 72% reduction in risk of progression or death ...
Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers
Monday, 28th April at 8:28 am
• Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer
• NT219's mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapies
REHOVOT, Israel, April 28, ...
Breakthrough: Novel Drug NT219 Stops Colorectal Cancer from Spreading to Brain, Study Shows
Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results
Can Purple Biotech's Newly Patented Cancer Drug Combination Tackle Treatment Resistance?
No comment yet